Cleared Traditional

K003711 - AMBULATORY BLOOD PRESSURE MONITORING SYSTEM, MODEL SE-25M/25P

K003711 is an FDA 510(k) clearance for AMBULATORY BLOOD PRESSURE MONITORING SYSTEM, manufactured by Sein Electronics Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K003711 · Sein Electronics Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2000
Decision
14d
Days
Class 2
Risk

K003711 is an FDA 510(k) clearance for the AMBULATORY BLOOD PRESSURE MONITORING SYSTEM, MODEL SE-25M/25P. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Sein Electronics Co., Ltd. (Anyang-City, Kyunggi-Do, KR). The FDA issued a Cleared decision on December 15, 2000 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K003711

510(k) Number K003711 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 2000
Decision Date December 15, 2000
Days to Decision 14 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 125d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
CHARLES MACK

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1213
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K003711.
WRISTWATCH BLOOD PRESSURE MONITOR, MODEL A43
K010190 · Rossmax Internationl , Ltd. · Feb 2001
BPC-3000 PERSONAL BLOOD PRESSURE COMMUNICATOR, MODEL 52520
K001543 · Welch Allyn, Inc. · Jan 2001
NONINVASIVE BLOOD PRESSURE MEASUREMENT SYSTEM
K002791 · Unix Electronic Co. , Ltd. · Jan 2001
MODEL WS-500 DIGITAL WRIST BLOOD PRESSURE MONITOR
K003444 · Nihon Seimitsu Sokki Co., Ltd. · Nov 2000
WELCH ALLYN SPOT CHECK DEVICE
K002530 · Welch Allyn, Inc. · Nov 2000
CVPROFILOR D0-2020 CARDIOVASCULAR PROFILING SYSTEM
K001948 · Hypertension Diagnostics, Inc. · Nov 2000
K003711 · AMBULATORY BLOOD PRESSURE MONITORING SYSTEM, MODEL SE-25M/25P
Download PDF FDA Summary Sein Electronics Co.,…